Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 36, 2006 - Issue 12
Submit an article Journal homepage
106
Views
5
CrossRef citations to date
0
Altmetric
Original

Glucuronidation in the chimpanzee (Pan troglodytes): Studies with acetaminophen, oestradiol and morphine

H. Wong Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USACorrespondence[email protected]
,
H. Wong Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USACorrespondence[email protected]
,
J. E. Grace Jr Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Wright Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
H. Wong Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USACorrespondence[email protected]
,
J. E. Grace Jr Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Wright Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Browning Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. J. Grossman Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. A. Bai Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
H. Wong Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USACorrespondence[email protected]
,
J. E. Grace Jr Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Wright Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Browning Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. J. Grossman Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. A. Bai Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
D. D. Christ Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
H. Wong Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USACorrespondence[email protected]
,
J. E. Grace Jr Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Wright Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
M. R. Browning Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. J. Grossman Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
,
S. A. Bai Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
&
D. D. Christ Metabolism and Pharmacokinetics, Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Co., Wallingford, CT, Wilmington, DE, Princeton, NJ and Newark, DE, USA
 show all
Pages 1178-1190 | Received 10 Jun 2006, Accepted 15 Jul 2006, Published online: 11 Aug 2009

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Swati Jaiswal, Abhisheak Sharma, Mahendra Shukla, Kalpesh Vaghasiya, Nagarjun Rangaraj & Jawahar Lal. (2014) Novel pre-clinical methodologies for pharmacokinetic drug–drug interaction studies: spotlight on “humanized” animal models. Drug Metabolism Reviews 46:4, pages 475-493.
Read now

Articles from other publishers (4)

Mohamed Ouzzine, Sandrine Gulberti, Nick Ramalanjaona, Jacques Magdalou & Sylvie Fournel-Gigleux. (2014) The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication. Frontiers in Cellular Neuroscience 8.
Crossref
Cuyue Tang & Thomayant Prueksaritanont. (2010) Use of In Vivo Animal Models to Assess Pharmacokinetic Drug-Drug Interactions. Pharmaceutical Research 27:9, pages 1772-1787.
Crossref
Thomayant Prueksaritanont. 2010. Enzyme- and Transporter-Based Drug-Drug Interactions. Enzyme- and Transporter-Based Drug-Drug Interactions 283 297 .
Bernard Testa & Stefanie D. Krämer. (2008) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 5:11, pages 2171-2336.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.